These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25178697)

  • 21. Voriconazole-induced skeletal fluorosis in an allogenic hematopoietic stem cell transplant recipient.
    Thekkudan SF; Kumar P; Nityanand S
    Ann Hematol; 2016 Mar; 95(4):669-70. PubMed ID: 26820975
    [No Abstract]   [Full Text] [Related]  

  • 22. Elevated fluoride levels and periostitis in pediatric hematopoietic stem cell transplant recipients receiving long-term voriconazole.
    Tarlock K; Johnson D; Cornell C; Parnell S; Meshinchi S; Baker KS; Englund JA
    Pediatr Blood Cancer; 2015 May; 62(5):918-20. PubMed ID: 25327935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of cyclosporine a and polymorphisms in
    Zeng G; Shi L; Li H; Wang L; Zhu M; Luo J; Zhang Z
    Xenobiotica; 2020 May; 50(5):614-619. PubMed ID: 31573401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorosis and periostitis deformans as complications of prolonged voriconazole treatment.
    Rad B; Saleem M; Grant S; Florkowski C; Coates P; Gordon D; Rankin W
    Ann Clin Biochem; 2015 Sep; 52(Pt 5):611-4. PubMed ID: 25587196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The challenges of treating aspergillus abdominal aneurysm after hematopoietic cell transplant: Rapid voriconazole metabolizer.
    Wasko JA; Ustun C; Birkenbach M; Faizer R; Green JS
    J Oncol Pharm Pract; 2019 Apr; 25(3):703-705. PubMed ID: 29285995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of CYP2C19 genotype with plasma voriconazole exposure in South-western Chinese Han patients with invasive fungal infections.
    Miao Q; Tang JT; van Gelder T; Li YM; Bai YJ; Zou YG; Wang LL; Shi YY
    Medicine (Baltimore); 2019 Jan; 98(3):e14137. PubMed ID: 30653146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug interaction between letermovir and voriconazole after allogeneic hematopoietic cell transplantation.
    Nakashima T; Inamoto Y; Fukushi Y; Doke Y; Hashimoto H; Fukuda T; Yamaguchi M
    Int J Hematol; 2021 Jun; 113(6):872-876. PubMed ID: 33677768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical investigation of reduced-dose voriconazole on primary prevention in invasive fungal disease after allogeneic hematopoietic stem cell transplantation].
    Qiu Z; Ren H; Cen X; Ou J; Xu W; Wang M; Wang L; Dong Y; Li Y; Liu W; Sun Y; Liang Z; Wang Q
    Zhonghua Xue Ye Xue Za Zhi; 2014 Jul; 35(7):577-80. PubMed ID: 25052595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary Cutaneous Aspergillosis in a Preterm Infant.
    Frick MA; Boix H; Camba Longueira F; Martin-Gomez MT; Rodrigo-Pendás JÁ; Soler-Palacin P
    Pediatr Infect Dis J; 2016 Jun; 35(6):704-6. PubMed ID: 26974892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Voriconazole-induced hepatotoxicity following the administration of PEG-asparaginase: Case report.
    Gallant R; Bonney P; Peek L; Yu Z; Crawford D
    Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27748018
    [No Abstract]   [Full Text] [Related]  

  • 31. Voriconazole exposure and risk of cutaneous squamous cell carcinoma among lung or hematopoietic cell transplant patients: A systematic review and meta-analysis.
    Tang H; Shi W; Song Y; Han J
    J Am Acad Dermatol; 2019 Feb; 80(2):500-507.e10. PubMed ID: 30130598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Voriconazole-Induced Periostitis After Allogeneic Stem Cell Transplantation.
    Haemels M; Pans S; Schoemans H; Goffin K; Gheysens O; Jentjens S
    Clin Nucl Med; 2019 Feb; 44(2):159-160. PubMed ID: 30516686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of flavin-containing monooxygenase 3 and CYP2C19 genotypes on plasma disposition and adverse effects of voriconazole administered orally in immunocompromised patients.
    Yamada T; Mino Y; Naito T; Kawakami J
    J Infect Chemother; 2019 Dec; 25(12):1019-1025. PubMed ID: 31239195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of CYP2C19*2/*17 genotype on adverse drug reactions of voriconazole in patients after allo-HSCT: a four-case report.
    Beata S; Donata UK; Jarosław D; Tomasz W; Anna WH
    J Cancer Res Clin Oncol; 2017 Jun; 143(6):1103-1106. PubMed ID: 28247033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic drug monitoring of voriconazole in Japanese patients: analysis based on clinical practice data.
    Matsumoto K; Abematsu K; Shigemi A; Kanazawa N; Watanabe E; Yokoyama Y; Ikawa K; Morikawa N; Takeda Y
    J Chemother; 2016 Jun; 28(3):198-202. PubMed ID: 26187373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of cytochrome P450 2C19 genotype on voriconazole exposure in cystic fibrosis lung transplant patients.
    Berge M; Guillemain R; Trégouet DA; Amrein C; Boussaud V; Chevalier P; Lillo-Lelouet A; Le Beller C; Laurent-Puig P; Beaune PH; Billaud EM; Loriot MA
    Eur J Clin Pharmacol; 2011 Mar; 67(3):253-60. PubMed ID: 21038076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Voriconazole-induced periostitis].
    Jakobsen DM; Justad BA; Helweg-Larsen J; Katzenstein TL
    Ugeskr Laeger; 2019 Apr; 181(18):. PubMed ID: 31036146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic drug monitoring and safety of intravenous voriconazole formulated with sulfobutylether β-cyclodextrin in haematological patients with renal impairment.
    Kim SH; Kwon JC; Park C; Han S; Yim DS; Choi JK; Cho SY; Lee HJ; Park SH; Choi SM; Choi JH; Yoo JH; Lee DG; Lee JW
    Mycoses; 2016 Oct; 59(10):644-51. PubMed ID: 27324913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistent poor long-term prognosis of allogeneic hematopoietic stem cell transplant recipients surviving invasive aspergillosis.
    Salmeron G; Porcher R; Bergeron A; Robin M; Peffault de Latour R; Ferry C; Rocha V; Petropoulou A; Xhaard A; Lacroix C; Sulahian A; Socié G; Ribaud P
    Haematologica; 2012 Sep; 97(9):1357-63. PubMed ID: 22371177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistent CNS toxicity in a patient receiving posaconazole tablets after discontinuation of voriconazole due to supratherapeutic serum levels.
    Foolad F; Kontoyiannis DP
    J Antimicrob Chemother; 2018 Jan; 73(1):256-258. PubMed ID: 29121264
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.